Published in Neurobiol Aging on November 05, 2014
Proaggregant nuclear factor(s) trigger rapid formation of α-synuclein aggregates in apoptotic neurons. Acta Neuropathol (2016) 0.80
A new glucocerebrosidase-deficient neuronal cell model provides a tool to probe pathophysiology and therapeutics for Gaucher disease. Dis Model Mech (2016) 0.75
Sterile Neuroinflammation and Strategies for Therapeutic Intervention. Int J Inflam (2017) 0.75
Purinergic Signalling: Therapeutic Developments. Front Pharmacol (2017) 0.75
Acidic Ca(2+) stores in neurodegeneration. Messenger (Los Angel) (2016) 0.75
Parkinson's disease: mechanisms and models. Neuron (2003) 14.84
Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc Natl Acad Sci U S A (2009) 3.99
Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J Biol Chem (2008) 2.86
Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of α-synuclein. J Neurosci (2011) 2.53
Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humans. Exp Neurol (2007) 2.15
Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol Neurodegener (2012) 2.11
Pathophysiology of cerebral ischemia and brain trauma: similarities and differences. J Cereb Blood Flow Metab (2004) 2.02
Heat-shock protein 70 modulates toxic extracellular α-synuclein oligomers and rescues trans-synaptic toxicity. FASEB J (2010) 1.90
Age-dependent synuclein pathology following traumatic brain injury in mice. Exp Neurol (2003) 1.89
Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity. Part Fibre Toxicol (2012) 1.87
Novel structurally altered P(2X1) receptor is preferentially activated by adenosine diphosphate in platelets and megakaryocytic cells. Blood (2001) 1.43
P2X receptors as drug targets. Mol Pharmacol (2012) 1.43
Neuroinflammation in Parkinson's disease. Parkinsonism Relat Disord (2012) 1.38
Brain-permeable small-molecule inhibitors of Hsp90 prevent alpha-synuclein oligomer formation and rescue alpha-synuclein-induced toxicity. J Pharmacol Exp Ther (2009) 1.38
Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration. FASEB J (2009) 1.33
Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway. J Neurosci (2005) 1.31
P2 receptors and extracellular ATP: a novel homeostatic pathway in inflammation. Front Biosci (Schol Ed) (2011) 1.31
Purinergic stimulation of rabbit ciliated airway epithelia: control by multiple calcium sources. J Physiol (1996) 1.23
Head injury and risk of Parkinson disease: a systematic review and meta-analysis. Mov Disord (2013) 1.21
Extracellular ATP mediates mast cell-dependent intestinal inflammation through P2X7 purinoceptors. Nat Commun (2012) 1.18
Traumatic brain injury, paraquat exposure, and their relationship to Parkinson disease. Neurology (2012) 1.17
Apoptosis-suppressor gene bcl-2 expression after traumatic brain injury in rats. J Neurosci (1997) 1.17
Activation and desensitization of the recombinant P2X1 receptor at nanomolar ATP concentrations. J Gen Physiol (2003) 1.16
Release of ATP in the central nervous system during systemic inflammation: real-time measurement in the hypothalamus of conscious rabbits. J Physiol (2007) 1.15
Extracellular nucleotides elicit cytosolic free calcium oscillations in Arabidopsis. Plant Physiol (2010) 1.10
Interaction between pathogenic proteins in neurodegenerative disorders. J Cell Mol Med (2012) 1.06
The role of extracellular adenosine in chemical neurotransmission in the hippocampus and Basal Ganglia: pharmacological and clinical aspects. Curr Top Med Chem (2011) 1.04
Dr. Jekyll/Mr. Hyde: the dual role of extracellular ATP. J Auton Nerv Syst (2000) 1.01
Adenosine monophosphate-activated protein kinase overactivation leads to accumulation of α-synuclein oligomers and decrease of neurites. Neurobiol Aging (2012) 1.01
Extracellular ATP exerts opposite effects on activated and regulatory CD4+ T cells via purinergic P2 receptor activation. J Immunol (2012) 0.99
Block of purinergic P2X(7) receptor is neuroprotective in an animal model of Alzheimer's disease. Neuroreport (2008) 0.99
α-Synuclein oligomers impair neuronal microtubule-kinesin interplay. J Biol Chem (2013) 0.98
Head trauma as a risk factor for Parkinson's disease. Mov Disord (1991) 0.93
Lysosomal alkalinization, lipid oxidation, and reduced phagosome clearance triggered by activation of the P2X7 receptor. FASEB J (2013) 0.93
Detecting adenosine triphosphate in the pericellular space. Interface Focus (2013) 0.92
Extracellular ATP and neurodegeneration. Curr Drug Targets CNS Neurol Disord (2003) 0.92
Purinoceptor-mediated calcium signaling in preglomerular smooth muscle cells. Hypertension (1999) 0.92
Generation of genetically-modified human differentiated cells for toxicological tests and the study of neurodegenerative diseases. ALTEX (2013) 0.89
Extracellular ATP-stimulated macrophages produce macrophage inflammatory protein-2 which is important for neutrophil migration. Immunology (2012) 0.86
Loss of substance P and inflammation precede delayed neurodegeneration in the substantia nigra after cerebral ischemia. Brain Behav Immun (2012) 0.86
Membrane compartments and purinergic signalling: P2X receptors in neurodegenerative and neuroinflammatory events. FEBS J (2008) 0.86
Dopamine-induced α-synuclein oligomers show self- and cross-propagation properties. Protein Sci (2014) 0.85
Cytochrome c release and endoplasmic reticulum stress are involved in caspase-dependent apoptosis induced by G418. Cell Mol Life Sci (2004) 0.84
Alpha-synuclein aggregation induced by brief ischemia negatively impacts neuronal survival in vivo: a study in [A30P]alpha-synuclein transgenic mouse. J Cereb Blood Flow Metab (2010) 0.83
Identification of P2X₃ and P2X₇ purinergic receptors activated by ATP in rat lacrimal gland. Invest Ophthalmol Vis Sci (2011) 0.83
Assessment of extracellular ATP concentrations. Methods Mol Biol (2009) 0.82
Lack of neuroprotection in the absence of P2X7 receptors in toxin-induced animal models of Parkinson's disease. Mol Neurodegener (2011) 0.82
Extracellular ATP activates NFAT-dependent gene expression in neuronal PC12 cells via P2X receptors. BMC Neurosci (2011) 0.79
Allosteric modulation of GABAA receptors by extracellular ATP. Mol Brain (2014) 0.76
Synuclein aggregation: possible role in traumatic brain injury. Exp Neurol (2003) 0.76